Vident Investment Advisory, LLC Veracyte, Inc. Transaction History

Vident Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $47,977 - $61,780	2,289 Added 23.06%	12,214 $311,000
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $204,256 - $276,808	9,925 New	9,925 $221,000
Q3 2021 Nov 12, 2021	SELL	$35.62 - $52.97 $192,348 - $286,038	-5,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.94 - $56.62 $177,876 - $305,748	5,400 New	5,400 $216,000

320

80.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.